Cargando…
Advanced prodrug strategies in nucleoside analogues targeting the treatment of gastrointestinal malignancies
Gastrointestinal malignancies are common digestive system tumor worldwide. Nucleoside analogues have been widely used as anticancer drugs for the treatment of a variety of conditions, including gastrointestinal malignancies. However, low permeability, enzymatic deamination, inefficiently phosphoryla...
Autores principales: | Xu, Xingxing, Li, Zixuan, Yao, Xueying, Sun, Nannan, Chang, Junbiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151537/ https://www.ncbi.nlm.nih.gov/pubmed/37143892 http://dx.doi.org/10.3389/fcell.2023.1173432 |
Ejemplares similares
-
Advances in antiviral nucleoside analogues and their prodrugs
por: Seley-Radtke, Katherine, et al.
Publicado: (2018) -
CRISPR/Cas9 in Gastrointestinal Malignancies
por: Jefremow, André, et al.
Publicado: (2021) -
Advances in RNA Epigenetic Modifications in Hepatocellular Carcinoma and Potential Targeted Intervention Strategies
por: Zhu, Li-Ran, et al.
Publicado: (2021) -
Mutation in Drosophila concentrative nucleoside transporter 1 alters spermatid maturation and mating behavior
por: Maaroufi, Houda Ouns, et al.
Publicado: (2022) -
Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years
por: Sinokrot, Hanadi, et al.
Publicado: (2017)